AIMEILI Profile: A Digital Service Platform for Medical Device Globalisation

Summary

AIMEILI (Ameli) is a brand of Beijing AIMEILI International Health Management Co., Ltd. It provides medical device companies with international market access, regulatory information management, overseas market development and digital support for going global. AIMEILI has built a digital go-global service brand for medical device companies covering product assessment, target market selection, overseas channel development, regulatory research, registration project management, company documentation management and business collaboration. Through an industry knowledge base, global regulatory data, market information, channel resources, project management tools and analytical support capabilities, the brand gives medical device companies information support and digital management tools for their overseas business.

This article is officially published by AIMEILI and introduces the brand positioning, core business, service system and development direction.

Source and applicability

• Source organisation: AIMEILI
• Original publication date: 11 August 2026
• Publication on this site: 11 August 2026, 13:46
• Article source: AIMEILI

Basic information

• Chinese name: 艾梅莉
• English name: Ameli (AIMEILI)
• Parent company: Beijing AIMEILI International Health Management Co., Ltd.
• Registration number: 76564877
• Industry: Medical device services; enterprise digital services
• Main business: International market access for medical devices; digital management of medical device go-global operations
• Service recipients: Medical device manufacturers, R&D companies, IVD companies, medical equipment companies, medical consumables companies and related organisations

Brand profile

AIMEILI primarily serves medical device companies with international expansion needs. Addressing common problems in internationalisation — scattered information, complex processes, insufficient specialist staff, difficult project coordination and a high dependence on individual experience — AIMEILI uses a digital platform to integrate industry knowledge, regulatory information, market data and business processes, providing supporting infrastructure for companies conducting international business.

Core business

Product file management

AIMEILI establishes a product file for each product, centrally managing product name, model, intended use, technical parameters, product classification, certification status, test documentation, instructions for use and related documents. The product master file is linked to individual target countries, market analyses, distributor resources and registration projects, reducing duplicated document preparation.

Product go-global analysis

Based on the product information and existing documentation submitted by the company, AIMEILI provides preliminary analysis of the product's internationalisation readiness. The analysis may cover:

• Completeness of product documentation
• Existing certifications and registrations
• Availability of English-language documentation
• Product market positioning
• Overseas after-sales support capability
• Conditions for international market development
• Items requiring supplementation or improvement

The output provides a data reference for overseas expansion decisions.

Global market analysis

AIMEILI collates information on the medical device market environment of different countries and regions, including market access, regulatory policy, competitive landscape, channel structure and related industry information. Companies can compare countries on the basis of product type, existing certifications, market positioning and business objectives, and use the comparison as a reference for target market selection.

Target country selection support

Drawing on product information and country data, AIMEILI performs a multi-criteria analysis of potential target markets. Relevant factors may include:

• Product regulatory classification
• Difficulty of market access
• Registration timelines
• Documentation requirements
• Local representative requirements
• Competitive situation
• Availability of channel resources
• Cost of entry for the company
• Market risk factors

Overseas channel resource management

AIMEILI maintains a channel information management system covering overseas medical device distributors, importers, channel service providers and related companies. Channel information may include:

• Basic company information
• Country and region
• Product categories handled
• Brands represented
• Channel type
• Business coverage
• Publicly available contact details
• Records of relevant industry events
• Information source
• Date of information update

Companies can filter, classify and manage channel resources according to product category and target market.

Channel matching support

On the basis of product characteristics, target country, product application scenario and publicly available information on channel companies, AIMEILI performs a matching analysis of potential partners. Matching factors may include:

• Relevance of product category
• Clinical department or application scenario
• Existing product lines
• Geographic coverage of the channel
• Import and registration capability
• Representation of competing products
• Level of business activity
• Completeness of available information

Overseas commercial support

AIMEILI provides business support tools for overseas sales personnel. Functions include:

• Background information compilation on overseas customers
• Preparation of product introduction materials
• Support for multilingual business content
• Drafting of business development emails
• Organisation of customer replies
• Follow-up task reminders
• Preparation of meeting materials
• Recording of opportunity stages

Overseas customer relationship management

AIMEILI provides a customer relationship management workflow suited to overseas medical device business. Companies can classify potential distributors, importers and partner organisations and record:

• Customer source
• Contact persons
• Dates of contact
• Communication records
• Customer requirements
• Sample status
• Quotation status
• Project stage
• Follow-up tasks
• Cooperation outcome

The resulting data can support internal sales management and business review.

Global regulatory information

AIMEILI continuously collates medical device regulatory regimes and market access requirements across countries and regions. Regulatory information mainly covers:

• Regulatory authorities
• Regulatory framework
• Product classification rules
• Registration pathways
• Submission documentation
• Quality management requirements
• Labelling and instructions for use requirements
• Unique Device Identification (UDI) requirements
• Local representative requirements
• Post-market surveillance
• Change and renewal requirements

Registration pathway support

Once a company selects a specific product and target country, AIMEILI can produce a registration pathway reference based on its established regulatory knowledge system. The output may include:

• Preliminary product classification
• Applicable regulatory pathway
• Documentation preparation checklist
• Project stages
• Estimated tasks
• Local entities likely to be involved
• Labelling and product information requirements
• Post-market related matters

Registration project management

AIMEILI supports companies in establishing medical device registration projects across different countries and regions. Project management content includes:

• Basic project information
• Products and models
• Target country
• Project owner
• Tasks
• Document list
• Project progress
• Deadlines
• Issue records
• Review records
• Certificate and renewal dates

Companies can view the progress of multiple products and multiple country projects on a single platform.

Company documentation management

AIMEILI provides documentation management functions for overseas operations. The following materials can be classified and archived:

• Product technical documentation
• Test reports
• Quality management system documents
• Registration certificates
• Labels and instructions for use
• Authorisation documents
• Contract materials
• Marketing materials
• Channel materials
• Project communication records

Through information such as document version, applicable country, applicable product and update date, AIMEILI improves the efficiency of document retrieval and reuse.

Management dashboard

For company management, AIMEILI consolidates information on products, markets, customers, registration projects and team tasks. Management can review:

• Product go-global readiness
• Target market analysis
• Number of channel resources
• Business development progress
• Registration project status
• Outstanding items
• Certificate expiry alerts
• Completion of team tasks
• Key business risks

Service system

The AIMEILI service system comprises the enterprise work platform, the industry data system, the analytical support system and the professional service support system.

• Enterprise work platform: for management, overseas sales staff, regulatory staff and project staff of medical device companies, providing product files, market analysis, channel management, regulatory search, project management and document collaboration.
• Industry data system: structured industry data covering medical device products, national markets, regulatory frameworks, market access and overseas channels.
• Analytical support system: uses data-processing tools to organise and provide preliminary analysis of product documentation uploaded by the company, publicly available regulatory information, market information and business data.
• Professional service support system: for complex submissions, regulatory judgements, local representative arrangements, technical file preparation and market access projects, AIMEILI can provide further support through qualified specialists or partner organisations.

AIMEILI also builds an industry knowledge system around the internationalisation of medical device companies.

• Country knowledge base: organised by country and region, covering regulatory authorities, regulatory framework, product classification, registration procedures, registration documentation, registration timelines, local representative, labelling requirements, UDI, post-market management, and market and channel environment.
• Regulatory knowledge base: built around international compliance topics, including medical device quality management systems, risk management, clinical evaluation, UDI, medical device software, software as a medical device and related technologies, labelling and instructions for use, post-market surveillance, adverse events and product recalls.
• Product knowledge base: organises baseline information and international market access characteristics by device category, use scenario and clinical purpose.
• Market knowledge base: collates the medical device market environment, channel models, procurement characteristics, industry policy and market developments in different countries and regions.
• Channel knowledge base: a classified information system covering overseas medical device importers, distributors, service organisations and related bodies, recording information source and verification status.
• Experience knowledge base: collates common issues, error types, risk points and handling approaches encountered by medical device companies going global, as a reference for project execution.

Who the services are for

AIMEILI primarily serves: medical device manufacturers; medical device R&D companies; in vitro diagnostic product companies; medical equipment companies; medical consumables companies; rehabilitation device companies; home-use device companies; medical software companies; medical device OEM and ODM companies; and service organisations in the medical device industry.

AIMEILI primarily supports the following situations:

• A company undertaking overseas medical device business for the first time
• Selecting target countries and regions
• Researching medical device regulatory requirements
• Identifying and managing overseas channels
• Developing overseas customers
• Managing international registration projects
• Managing products and registration documentation
• Building an internal knowledge base for overseas business
• Coordinating projects across departments
• Managing multiple products and multi-country projects

Brand characteristics

• Vertical industry application: AIMEILI focuses exclusively on the medical device industry, and its functions and workflows are designed around the characteristics of overseas business in this sector.
• End-to-end management: coverage of product analysis, market selection, channel development, regulatory access, project execution and documentation management.
• Structured data: regulatory, country, product, channel and project information is managed in a structured way, enabling search, filtering, linking and reuse.
• Analytical assistance: processing tools handle repetitive information-organisation and content-drafting tasks to improve staff efficiency.
• Human oversight and system collaboration: responsibilities are divided between processing tools, company staff and professional advisers. Routine tasks are supported by the system; material business and regulatory matters are reviewed by the responsible personnel.
• Business data accumulation: product, market, channel and project records can be used for ongoing business management, experience accumulation and project review.

Brand positioning

AIMEILI is positioned as a digital service brand for the global development of medical device companies. It builds corresponding digital functions and knowledge systems across the full process from go-global preparation, market selection and channel development to regulatory access and project management.

Development directions include: global medical device regulatory information management; international market access management; go-global readiness analysis for medical device products; overseas market and target country analysis; overseas channel resource management; medical device registration project management; company documentation management for overseas business; analytical support; and business collaboration for overseas operations.

Brand development

Development priorities: improving the global medical device regulatory database; building a structured country market database; developing an overseas channel resource system; enhancing product-to-market matching capability; strengthening analytical applications for the medical device industry; building a business collaboration system for overseas operations; establishing information verification and professional review mechanisms; and expanding the international market service network for medical devices.

Development objective: to integrate the industry knowledge, data resources, online tools and standardised business processes required by medical device companies going global, simplify cross-border compliance and overseas expansion work through a digital platform, reduce the manual effort spent on repetitive tasks and improve cross-functional collaboration efficiency within companies.

AIMEILI regulatory interpretation

This publication is a brand and service-profile statement rather than a regulatory policy update, so it does not by itself change any market access requirement. Its regulatory significance lies in the scope of the information categories it describes. The regulatory elements listed — product classification rules, registration pathways, submission documentation, quality management requirements, labelling and instructions for use, UDI, local representative arrangements, post-market surveillance, and change and renewal obligations — correspond directly to the core building blocks of market access dossiers in major jurisdictions. Companies should read the profile as a map of the documentation and intelligence domains they are expected to govern, not as evidence that any particular requirement has been met.

A second point concerns the status of platform outputs. Product classification indications, registration pathway references, documentation checklists and target country comparisons are preliminary assessments intended for planning and gap identification. They do not replace the concluded classification of the target regulator, formal technical review, test reports or legal advice. Where a pathway reference influences a submission strategy, the underlying regulatory basis should be re-verified against the current official text of the target authority before any dossier is finalised.

A third point concerns documentation control. The profile describes centralised management of technical documentation, test reports, quality system records, certificates, labels and instructions for use, authorisation documents and project correspondence, with version, applicable country and applicable product attributes. From a compliance perspective, this aligns with the traceability expectations of ISO 13485-based quality systems and with the audit trail requirements that notified bodies and regulators apply to technical documentation and post-market records. Structured version control is a control weakness worth closing regardless of which platform a company uses.

Business impact

• Earlier gap identification: readiness analysis and pathway references allow regulatory affairs teams to identify missing evidence — performance data, clinical evaluation, English-language documentation, labelling localisation — before distributor negotiations or submission timelines commit the company.
• Portfolio-level oversight: consolidated views of multiple products across multiple countries support certificate expiry tracking and renewal planning, which is a frequent source of avoidable market interruption.
• Channel due diligence records: documented channel information, including source and update date, supports distributor qualification, agreement negotiation and post-market traceability obligations that fall on the legal manufacturer or its authorised representative.
• Role clarity across the supply chain: for distributors, importers and authorised representatives, structured project and documentation records make obligations on local registration, labelling and vigilance reporting easier to allocate and evidence.
• Positioning for CROs and regulatory consultancies: platform-based preparation is complementary to, not a substitute for, formal regulatory services. Complex submissions, local representative arrangements and technical file preparation still require qualified specialist review, and companies should define the handover point between internal preparation and external support.
• Audit readiness: accumulated product, market, channel and project records form a retrievable history that can be produced during quality system audits, supplier audits and post-market inspections, provided retention periods and access controls are defined.

FAQ

Can this AIMEILI profile be used directly as a basis for a regulatory submission?

No. This article supports preliminary understanding and project assessment only. A formal submission must be based on the latest requirements of the regulatory authority in the target country, the concluded product classification and the company's actual documentation status.

What should a company do first after reading this profile?

A documentation gap assessment should be carried out first, confirming whether the information affects the registration pathway, technical documentation, labelling, quality management system or post-market maintenance.

Content review and scope of application

• Content author: AIMEILI Regulatory Editorial Team
• Professional review: AIMEILI International Medical Device Registration Project Team
• Source principles: official regulatory authorities, international organisations, standards bodies and publicly available regulatory materials are prioritised; industry media and project experience are used only as supporting judgement.
• Scope of application: this article is intended for preliminary understanding, documentation preparation and project planning. It does not replace the formal requirements of the regulatory authority in the target country, test conclusions or legal advice.

Related reading

• 31 July 2026 — NMPA Center for Medical Device Evaluation seeks public comment on the technical review points for clinical trials of implanted brain-computer interface hand motor function compensation systems
• WHO publishes PFAS landscape review (does not meet AIMEILI news admission criteria)
• 27 July 2026 — Health Canada consults on changes to the list of recognised medical device standards
• 9 July 2026 — FDA issues early alert on Baxter intravascular administration sets
• 14 July 2026 — FDA seeks comment on specific non-device software functions
• WHO publishes safety assessment of contaminants in food

Contact AIMEILI

Need to assess a registration pathway? Please provide the product name, intended use, target country and existing documentation base. AIMEILI can assist in determining the registration pathway, documentation gaps and compliance risks.